Editas Medicine, Inc.(EDIT)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

EDIT Editas Medicine, Inc.

已收盘 11-22 16:00:00 EST

2.44

+0.07

+2.95%

盘后2.45

+0.01+0.41%

19:45 EST

最高2.54	最低2.33	成交量227.74万
今开2.39	昨收2.37	日振幅8.65%
总市值2.01亿	流通市值1.89亿	总股本8,255万
成交额558.64万	换手率2.95%	流通股本7,732万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"EDIT","market":"US","secType":"STK","nameCN":"Editas Medicine, Inc.","latestPrice":2.44,"timestamp":1732309200000,"preClose":2.37,"halted":0,"volume":2277431,"hourTrading":{"tag":"盘后","latestPrice":2.45,"preClose":2.44,"latestTime":"19:45 EST","volume":28731,"amount":70301.5815,"timestamp":1732322738361},"delay":0,"floatShares":77323761,"shares":82548099,"eps":-2.563959,"marketStatus":"已收盘","marketStatusCode":5,"change":0.07,"latestTime":"11-22 16:00:00 EST","open":2.39,"high":2.535,"low":2.33,"amount":5586354.2265752,"amplitude":0.086498,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.563959,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1732525200000},"adr":0,"adjPreClose":2.37,"adrRate":0,"preHourTrading":{"tag":"盘前","latestPrice":2.4,"preClose":2.37,"latestTime":"09:18 EST","volume":3435,"amount":8159.967534,"timestamp":1732285133308},"postHourTrading":{"tag":"盘后","latestPrice":2.45,"preClose":2.44,"latestTime":"19:45 EST","volume":28731,"amount":70301.5815,"timestamp":1732322738361},"volumeRatio":0.917256,"impliedVol":0.5545,"impliedVolPercentile":0.0556},"requestUrl":"/m/hq/s/EDIT/wiki","defaultTab":"wiki","newsList":[{"id":"2485299201","title":"Editas Medicine, Inc.盘中异动 快速拉升5.01%报2.49美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485299201","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485299201?lang=zh_cn&edition=full","pubTime":"2024-11-23 01:10","pubTimestamp":1732295448,"startTime":"0","endTime":"0","summary":"北京时间2024年11月23日01时10分，Editas Medicine, Inc.股票出现异动，股价快速拉升5.01%。Editas Medicine, Inc.股票所在的生物技术行业中，整体涨幅为0.73%。其相关个股中，Ocean Biomedical Inc C/Wts 14/02/2028 、Apollomics Inc C/Wts 01/04/2028 、Exicure, Inc.涨幅较大，Virpax Pharmaceuticals, Inc.、Exicure, Inc.、Molecular Templates, Inc.较为活跃，换手率分别为1829.24%、145.93%、92.20%，振幅较大的相关个股有Virpax Pharmaceuticals, Inc.、Ocean Biomedical Inc C/Wts 14/02/2028 、Apollomics Inc C/Wts 01/04/2028 ，振幅分别为72.58%、71.43%、63.64%。Editas Medicine, Inc.公司简介：Editas Medicine Inc 是一家临床阶段基因组编辑公司，致力于开发具有潜在变革性的基因组药物来治疗各种严重疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123011048abd7d271&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123011048abd7d271&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4556","BK4139","EDIT"],"gpt_icon":0},{"id":"2485124267","title":"Editas Medicine, Inc.盘中异动 下午盘大幅下挫5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485124267","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485124267?lang=zh_cn&edition=full","pubTime":"2024-11-21 03:16","pubTimestamp":1732130208,"startTime":"0","endTime":"0","summary":"北京时间2024年11月21日03时16分，Editas Medicine, Inc.股票出现波动，股价快速下跌5.24%。Editas Medicine, Inc.股票所在的生物技术行业中，整体涨幅为0.24%。其相关个股中，Forte Biosciences, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Exicure, Inc.涨幅较大，Forte Biosciences, Inc.、Silexion Therapeutics Corp、Exicure, Inc.较为活跃，换手率分别为1854.14%、1325.46%、974.44%，振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Forte Biosciences, Inc.、Exicure, Inc.，振幅分别为185.64%、169.09%、136.94%。Editas Medicine, Inc.公司简介：Editas Medicine Inc 是一家临床阶段基因组编辑公司，致力于开发具有潜在变革性的基因组药物来治疗各种严重疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121031648a2493d33&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121031648a2493d33&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EDIT","BK4556","BK4139"],"gpt_icon":0},{"id":"2484024366","title":"Editas Medicine, Inc.盘中异动 急速下挫5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484024366","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484024366?lang=zh_cn&edition=full","pubTime":"2024-11-19 02:44","pubTimestamp":1731955456,"startTime":"0","endTime":"0","summary":"北京时间2024年11月19日02时44分，Editas Medicine, Inc.股票出现异动，股价急速下跌5.08%。Editas Medicine, Inc.股票所在的生物技术行业中，整体涨幅为0.09%。其相关个股中，Hcw Biologics Inc.、冠科美博、Apollomics Inc C/Wts 01/04/2028 涨幅较大，冠科美博、Hcw Biologics Inc.、Tharimmune, Inc.较为活跃，换手率分别为1256.58%、1206.59%、567.30%，振幅较大的相关个股有Hcw Biologics Inc.、冠科美博、Apollomics Inc C/Wts 01/04/2028 ，振幅分别为563.48%、221.58%、193.44%。Editas Medicine, Inc.公司简介：Editas Medicine Inc 是一家临床阶段基因组编辑公司，致力于开发具有潜在变革性的基因组药物来治疗各种严重疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119024416971a7410&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119024416971a7410&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EDIT","BK4556","BK4139"],"gpt_icon":0},{"id":"2483331568","title":"Editas Medicine, Inc.盘中异动 快速跳水5.07%报2.81美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483331568","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483331568?lang=zh_cn&edition=full","pubTime":"2024-11-15 04:04","pubTimestamp":1731614695,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日04时04分，Editas Medicine, Inc.股票出现异动，股价急速下跌5.07%。Editas Medicine, Inc.股票所在的生物技术行业中，整体跌幅为1.27%。Editas Medicine, Inc.公司简介：Editas Medicine Inc 是一家临床阶段基因组编辑公司，致力于开发具有潜在变革性的基因组药物来治疗各种严重疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111504045598e42b8c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111504045598e42b8c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4556","BK4139","EDIT"],"gpt_icon":0},{"id":"2482087984","title":"Editas Medicine, Inc.盘中异动 早盘股价大跌5.00%报3.14美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2482087984","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482087984?lang=zh_cn&edition=full","pubTime":"2024-11-12 23:39","pubTimestamp":1731425954,"startTime":"0","endTime":"0","summary":"北京时间2024年11月12日23时39分，Editas Medicine, Inc.股票出现异动，股价急速下跌5.00%。截至发稿，该股报3.14美元/股，成交量42.2221万股，换手率0.51%，振幅3.39%。Editas Medicine, Inc.股票所在的生物技术行业中，整体跌幅为0.32%。Editas Medicine, Inc.公司简介：Editas Medicine Inc 是一家临床阶段基因组编辑公司，致力于开发具有潜在变革性的基因组药物来治疗各种严重疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111223391498e421d5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111223391498e421d5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4556","BK4139","EDIT"],"gpt_icon":0},{"id":"2482836734","title":"Editas Medicine, Inc.2024财年第三财季实现净利润-62.14百万美元，同比减少38.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482836734","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482836734?lang=zh_cn&edition=full","pubTime":"2024-11-12 00:00","pubTimestamp":1731340828,"startTime":"0","endTime":"0","summary":"11月12日，Editas Medicine, Inc.公布财报，公告显示公司2024财年第三财季净利润为-62.14百万美元，同比减少38.03%；其中营业收入为61000.00美元，同比减少98.86%，每股基本收益为-0.75美元。从资产负债表来看，Editas Medicine, Inc.总负债1.52亿美元，其中短期债务16.39百万美元，资产负债比为2.16，流动比率为0.04。机构评级：截至2024年11月12日，当前有13家机构对Editas Medicine, Inc.目标价做出预测，其中目标均价为9.08美元，其中最低目标价为4.00美元，最高目标价为15.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112000035a22d0d6f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112000035a22d0d6f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EDIT"],"gpt_icon":0},{"id":"2482802738","title":"Editas Medicine, Inc.盘中异动 急速上涨5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482802738","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482802738?lang=zh_cn&edition=full","pubTime":"2024-11-11 22:31","pubTimestamp":1731335517,"startTime":"0","endTime":"0","summary":"北京时间2024年11月11日22时31分，Editas Medicine, Inc.股票出现波动，股价快速拉升5.13%。Editas Medicine, Inc.股票所在的生物技术行业中，整体跌幅为0.05%。Editas Medicine, Inc.公司简介：Editas Medicine Inc 是一家临床阶段基因组编辑公司，致力于开发具有潜在变革性的基因组药物来治疗各种严重疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111223200971a5ae2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111223200971a5ae2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4556","EDIT"],"gpt_icon":0},{"id":"2481675071","title":"Editas Medicine, Inc.盘中异动 早盘股价大跌5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481675071","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481675071?lang=zh_cn&edition=full","pubTime":"2024-11-08 00:19","pubTimestamp":1730996352,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日00时19分，Editas Medicine, Inc.股票出现异动，股价大幅下挫5.17%。Editas Medicine, Inc.股票所在的生物技术行业中，整体涨幅为0.11%。其相关个股中，Celularity Inc.、Ensysce Biosciences, Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 涨幅较大，Ensysce Biosciences, Inc.、Elevai Labs, Inc.、Cyclacel Pharmaceuticals, Inc.较为活跃，换手率分别为823.77%、288.90%、100.95%，振幅较大的相关个股有Celularity Inc.、180 Life Sciences Corp C/Wts 07/11/2025、Ensysce Biosciences, Inc.，振幅分别为84.83%、68.89%、57.79%。Editas Medicine, Inc.公司简介：Editas Medicine Inc 是一家临床阶段基因组编辑公司，致力于开发具有潜在变革性的基因组药物来治疗各种严重疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108001913971a5254&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108001913971a5254&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","EDIT","BK4556"],"gpt_icon":0},{"id":"2481768177","title":"Editas Medicine, Inc.盘中异动 早盘股价大涨5.03%报3.03美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481768177","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481768177?lang=zh_cn&edition=full","pubTime":"2024-11-05 23:45","pubTimestamp":1730821515,"startTime":"0","endTime":"0","summary":"北京时间2024年11月05日23时45分，Editas Medicine, Inc.股票出现异动，股价快速上涨5.03%。Editas Medicine, Inc.股票所在的生物技术行业中，整体涨幅为0.68%。Editas Medicine, Inc.公司简介：Editas Medicine Inc 是一家临床阶段基因组编辑公司，致力于开发具有潜在变革性的基因组药物来治疗各种严重疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110523451598e40960&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110523451598e40960&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","EDIT","BK4556"],"gpt_icon":0},{"id":"2481541559","title":"美国研究综述-信诺、万豪、拉尔夫-劳伦","url":"https://stock-news.laohu8.com/highlight/detail?id=2481541559","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481541559?lang=zh_cn&edition=full","pubTime":"2024-11-05 15:04","pubTimestamp":1730790257,"startTime":"0","endTime":"0","summary":"    路透11月5日 - 华尔街证券分析师周二调整了对几家美国上市公司的评级和目标价，其中包括 Cigna、万豪和 Ralph Lauren。要闻             * Cigna   ：Piper Sandler将目标价从392美元上调至394美元             * 万豪  ：杰富瑞将目标价从 225 美元上调至 251 美元              * Ralph Lauren Corp   ：TD Cowen 将目标价从 208 美元上调至 251 美元              * Vertex Pharmaceuticals Inc   ：丰业银行将目标价从480美元上调至486美元             * Wynn Resorts Ltd   ：摩根大通将目标价从101美元上调至113美元  以下是路透周二报导的美国公司研究报告摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IRON","CI","NYT","EGHT","FIS","FOXA","OMI","ARES","RL","HIMS","GKOS","NMRA","ATUS","CSTL","LU0971096721.USD","INSP","SLAB","LU0320765489.SGD","MDGL","LU1489326972.SGD","BK4106","PTGX","LU0149725797.USD","BMRN","ILMN","LU1363072403.SGD","BWIN","KROS","AMG","LU0949170772.SGD","LU0266512127.USD","LU1244550221.USD","MAR","CMS","BEN","SHAK","LU","IE00BZ1G4Q59.USD","EVER","ST","CAMP","SM","RZLT","FRPT","AWI","EDIT","LSCC"],"gpt_icon":1},{"id":"2481415545","title":"美国研究综述-信诺、万豪、拉尔夫-劳伦","url":"https://stock-news.laohu8.com/highlight/detail?id=2481415545","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481415545?lang=zh_cn&edition=full","pubTime":"2024-11-05 15:04","pubTimestamp":1730790257,"startTime":"0","endTime":"0","summary":"    路透11月5日 - 华尔街证券分析师周二调整了对几家美国上市公司的评级和目标价，其中包括 Cigna、万豪和 Ralph Lauren。要闻             * Cigna   ：Piper Sandler将目标价从392美元上调至394美元             * 万豪  ：杰富瑞将目标价从 225 美元上调至 251 美元              * Ralph Lauren Corp   ：TD Cowen 将目标价从 208 美元上调至 251 美元              * Vertex Pharmaceuticals Inc   ：丰业银行将目标价从480美元上调至486美元             * Wynn Resorts Ltd   ：摩根大通将目标价从101美元上调至113美元  以下是路透周二报道的美国公司研究报告摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BWIN","EGHT","ILMN","NYT","RL","GKOS","BMRN","AWI","LU","LU1363072403.SGD","RZLT","IE00BZ1G4Q59.USD","IRON","MDGL","PTGX","CI","LU1489326972.SGD","AMG","LU0971096721.USD","BK4106","FOXA","NMRA","LU0149725797.USD","MAR","FIS","LU1244550221.USD","OMI","FRPT","INSP","EDIT","SHAK","BEN","LU0320765489.SGD","CAMP","SLAB","EVER","LSCC","SM","ATUS","LU0266512127.USD","ST","CSTL","CMS","LU0949170772.SGD","KROS","ARES"],"gpt_icon":1},{"id":"2480874175","title":"Editas 医药公司公布截至 9 月 30 日的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2480874175","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480874175?lang=zh_cn&edition=full","pubTime":"2024-11-04 23:30","pubTimestamp":1730734251,"startTime":"0","endTime":"0","summary":"   * Editas Medicine Inc    公布了截至 9 月 30 日的季度调整后每股亏损 75 美分，低于去年同期的每股收益-55 美分。华尔街预期为每股-96美分至-13美分。* 营收同比下降 98.9%，为 6100 万美元；分析师预期为 224 万美元。* Editas Medicine Inc 公布的本季度每股收益为亏损 75 美分。* 该公司当季亏损 6214 万美元。* Editas Medicine Inc 本季度股价下跌了 14.7%，今年迄今为止下跌了 71.3%。华尔街对 Editas Medicine Inc 的 12 个月目标价中位数为 10.00 美元。本摘要由 LSEG 11 月 4 日 03:30 p.m. UTC 调制解调器器生成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Editas 医药公司公布截至 9 月 30 日的季度业绩 - 收益摘要","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4556","EDIT","BK4139"],"gpt_icon":0},{"id":"2480584353","title":"Editas Medicine, Inc.盘中异动 早盘大幅下跌5.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480584353","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480584353?lang=zh_cn&edition=full","pubTime":"2024-11-04 22:37","pubTimestamp":1730731023,"startTime":"0","endTime":"0","summary":"北京时间2024年11月04日22时37分，Editas Medicine, Inc.股票出现异动，股价快速跳水5.33%。Editas Medicine, Inc.股票所在的生物技术行业中，整体跌幅为0.16%。其相关个股中，Briacell Therapeutics Corp C/Wts 24/02/2025、Disc Medicine, Inc.、Neurogene Inc.涨幅较大，Nls Pharmaceutics Ltd.、Elevai Labs, Inc.、Gri Bio, Inc.较为活跃，换手率分别为238.58%、143.10%、47.14%，振幅较大的相关个股有Briacell Therapeutics Corp C/Wts 24/02/2025、Psyence Biomedical Ltd C/Wts 25/01/2029、Kalvista Pharmaceuticals, Inc.，振幅分别为29.83%、22.67%、17.81%。Editas Medicine, Inc.公司简介：Editas Medicine Inc 是一家临床阶段基因组编辑公司，致力于开发具有潜在变革性的基因组药物来治疗各种严重疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110422370498e40491&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110422370498e40491&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","EDIT","BK4556"],"gpt_icon":0},{"id":"2479885427","title":"Editas Medicine Inc    预计每股亏损 75 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2479885427","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479885427?lang=zh_cn&edition=full","pubTime":"2024-10-30 21:27","pubTimestamp":1730294835,"startTime":"0","endTime":"0","summary":"   * Editas Medicine Inc    预计将在11月1日公布截至2024年9月30日的业绩报告(估计)，季度收入将出现下降。* 根据LSEG的数据，14位分析师的平均预期显示，这家总部位于马萨诸塞州剑桥市的公司预计营收将从去年同期的534万美元下降57.9%，至224.5万美元。* LSEG 分析师对 Editas Medicine Inc 的平均预期是每股亏损 75 美分。* 华尔街对 Editas Medicine Inc 的 12 个月目标价中位数为 10.00 美元，高于其上一次收盘价 3.11 美元。10月30日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Editas Medicine Inc    预计每股亏损 75 美分 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EDIT"],"gpt_icon":0},{"id":"2479258879","title":"Editas Medicine, Inc.盘中异动 大幅下跌5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479258879","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479258879?lang=zh_cn&edition=full","pubTime":"2024-10-30 02:17","pubTimestamp":1730225861,"startTime":"0","endTime":"0","summary":"北京时间2024年10月30日02时17分，Editas Medicine, Inc.股票出现异动，股价急速跳水5.06%。Editas Medicine, Inc.股票所在的生物技术行业中，整体跌幅为0.17%。Editas Medicine, Inc.公司简介：Editas Medicine Inc 是一家临床阶段基因组编辑公司，致力于开发具有潜在变革性的基因组药物来治疗各种严重疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103002174198e3f2af&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103002174198e3f2af&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4556","BK4139","EDIT"],"gpt_icon":0},{"id":"2478376249","title":"Editas Medicine, Inc.盘中异动 大幅拉升5.03%报3.34美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478376249","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478376249?lang=zh_cn&edition=full","pubTime":"2024-10-25 23:12","pubTimestamp":1729869171,"startTime":"0","endTime":"0","summary":"北京时间2024年10月25日23时12分，Editas Medicine, Inc.股票出现异动，股价大幅拉升5.03%。Editas Medicine, Inc.股票所在的生物技术行业中，整体涨幅为0.80%。其相关个股中，Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 、Immunitybio, Inc.、Elevai Labs, Inc.涨幅较大，180 Life Sciences Corp.、Elevai Labs, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为767.06%、715.27%、195.53%，振幅较大的相关个股有Qualigen Therapeutics, Inc.、Elevai Labs, Inc.、Tevogen Bio Holdings Inc C/Wts 14/02/2029 ，振幅分别为91.58%、85.14%、78.01%。Editas Medicine, Inc.公司简介：Editas Medicine Inc 是一家临床阶段基因组编辑公司，致力于开发具有潜在变革性的基因组药物来治疗各种严重疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102523125198e3e8a7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102523125198e3e8a7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["EDIT","BK4556","BK4139"],"gpt_icon":0},{"id":"2477534961","title":"美股异动 | 富国银行下调目标价至9美元 Editas Medicine(EDIT.US)跌逾2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477534961","media":"智通财经","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477534961?lang=zh_cn&edition=full","pubTime":"2024-10-23 22:39","pubTimestamp":1729694363,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，周三，Editas Medicine(EDIT.US)股价走低，截至发稿，下跌2.58%，报3.205美元。消息面上，富国银行分析师Yanan Zhu维持对Editas Medicine的等权重评级，并将目标价从27美元降至9美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1198443.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["EDIT"],"gpt_icon":0},{"id":"2477732864","title":"Editas Medicine, Inc.盘中异动 快速拉升5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2477732864","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477732864?lang=zh_cn&edition=full","pubTime":"2024-10-21 23:03","pubTimestamp":1729523011,"startTime":"0","endTime":"0","summary":"北京时间2024年10月21日23时03分，Editas Medicine, Inc.股票出现波动，股价大幅拉升5.06%。Editas Medicine, Inc.股票所在的生物技术行业中，整体跌幅为0.49%。其相关个股中，Genprex, Inc.、Biovie Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Genprex, Inc.、Gri Bio, Inc.、Biovie Inc.较为活跃，换手率分别为5339.39%、2923.05%、1217.19%，振幅较大的相关个股有Genprex, Inc.、Biovie Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为335.84%、157.02%、131.05%。Editas Medicine, Inc.公司简介：Editas Medicine Inc 是一家临床阶段基因组编辑公司，致力于开发具有潜在变革性的基因组药物来治疗各种严重疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241021230331a1e24e6b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241021230331a1e24e6b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","EDIT","BK4556"],"gpt_icon":0},{"id":"2476043321","title":"Editas Medicine, Inc.盘中异动 股价大跌5.07%报3.28美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2476043321","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476043321?lang=zh_cn&edition=full","pubTime":"2024-10-18 00:12","pubTimestamp":1729181546,"startTime":"0","endTime":"0","summary":"北京时间2024年10月18日00时12分，Editas Medicine, Inc.股票出现波动，股价大幅下挫5.07%。截至发稿，该股报3.28美元/股，成交量44.4105万股，换手率0.54%，振幅6.12%。Editas Medicine, Inc.股票所在的生物技术行业中，整体涨幅为0.73%。Editas Medicine, Inc.公司简介：Editas Medicine Inc 是一家临床阶段基因组编辑公司，致力于开发具有潜在变革性的基因组药物来治疗各种严重疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241018001227ab6ade22&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241018001227ab6ade22&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4556","EDIT"],"gpt_icon":0},{"id":"2475066195","title":"Editas Medicine, Inc.盘中异动 股价大涨5.09%报3.41美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2475066195","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475066195?lang=zh_cn&edition=full","pubTime":"2024-10-16 03:25","pubTimestamp":1729020322,"startTime":"0","endTime":"0","summary":"北京时间2024年10月16日03时25分，Editas Medicine, Inc.股票出现波动，股价大幅上涨5.09%。Editas Medicine, Inc.股票所在的生物技术行业中，整体跌幅为0.54%。Editas Medicine, Inc.公司简介：Editas Medicine Inc 是一家临床阶段基因组编辑公司，致力于开发具有潜在变革性的基因组药物来治疗各种严重疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241016032522a1e0e032&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241016032522a1e0e032&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4556","EDIT","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.editasmedicine.com","stockEarnings":[{"period":"1week","weight":-0.1444},{"period":"1month","weight":-0.2796},{"period":"3month","weight":-0.3876},{"period":"6month","weight":-0.579},{"period":"1year","weight":-0.7741},{"period":"ytd","weight":-0.766}],"compareEarnings":[{"period":"1week","weight":0.0005},{"period":"1month","weight":0.0177},{"period":"3month","weight":0.0561},{"period":"6month","weight":0.1213},{"period":"1year","weight":0.3047},{"period":"ytd","weight":0.249}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Editas Medicine, Inc.于2013年9月以Gengine, Inc.名字成立，后来在2013年11月更名为Editas Medicine, Inc.该公司是一家领先的基因研究公司，致力于通过纠正患者的致病基因治疗与基因相关的疾病。","yearOnYearQuotes":[{"month":1,"riseRate":0.375,"avgChangeRate":-0.061207},{"month":2,"riseRate":0.375,"avgChangeRate":0.022799},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.0355},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.074249},{"month":5,"riseRate":0.444444,"avgChangeRate":-0.003432},{"month":6,"riseRate":0.555556,"avgChangeRate":0.068829},{"month":7,"riseRate":0.666667,"avgChangeRate":0.023875},{"month":8,"riseRate":0.555556,"avgChangeRate":0.037553},{"month":9,"riseRate":0.111111,"avgChangeRate":-0.123756},{"month":10,"riseRate":0.444444,"avgChangeRate":-0.052997},{"month":11,"riseRate":0.555556,"avgChangeRate":0.108086},{"month":12,"riseRate":0.375,"avgChangeRate":0.101676}],"exchange":"NASDAQ","name":"Editas Medicine, Inc.","nameEN":"Editas Medicine"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Editas Medicine, Inc.(EDIT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Editas Medicine, Inc.(EDIT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Editas Medicine, Inc.,EDIT,Editas Medicine, Inc.股票,Editas Medicine, Inc.股票老虎,Editas Medicine, Inc.股票老虎国际,Editas Medicine, Inc.行情,Editas Medicine, Inc.股票行情,Editas Medicine, Inc.股价,Editas Medicine, Inc.股市,Editas Medicine, Inc.股票价格,Editas Medicine, Inc.股票交易,Editas Medicine, Inc.股票购买,Editas Medicine, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Editas Medicine, Inc.(EDIT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Editas Medicine, Inc.(EDIT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况